Validation and clinical application of transactivation assays for RUNX1 variant classification

Familial platelet disorder with associated myeloid malignancies (RUNX1-familial platelet disorder [RUNX1-FPD]) is caused by heterozygous pathogenic germline variants of RUNX1. In the present study, we evaluate the applicability of transactivation assays to investigate RUNX1 variants in different reg...

Descripción completa

Detalles Bibliográficos
Autores principales: Decker, Melanie, Agarwal, Anupriya, Benneche, Andreas, Churpek, Jane, Duployez, Nicolas, Duvall, Adam, Ernst, Martijn P. T., Förster, Alisa, Høberg-Vetti, Hildegunn, Hofmann, Inga, Nash, Michelle, Raaijmakers, Marc H. G. P., Tvedt, Tor H. A., Vlachos, Adrianna, Schlegelberger, Brigitte, Illig, Thomas, Ripperger, Tim
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Hematology 2022
Materias:
Stimulus Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9198940/
https://www.ncbi.nlm.nih.gov/pubmed/35026845
http://dx.doi.org/10.1182/bloodadvances.2021006161

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9198940/
https://www.ncbi.nlm.nih.gov/pubmed/35026845
http://dx.doi.org/10.1182/bloodadvances.2021006161

Ejemplares similares